Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Cell Surface (Amsterdam, Netherlands)|October 10, 2025
Pathogenic diversity of Cryptococcus in Galleria mellonella extends beyond classical virulence factorsBianca A G Sena, Marlon D M Santos, Cassia M Souza, et al.
JAMIA Open|November 29, 2023
Evaluating the impact of alternative phenotype definitions on incidence rates across a global data networkRupa Makadia, Azza Shoaibi, Gowtham A Rao, et al.
Journal of Cellular and Molecular Medicine|July 22, 2020
Ablation of sensory nerves favours melanoma progressionPedro H D M Prazeres, Caroline Leonel, Walison N Silva, et al.
The Lancet. Rheumatology|January 17, 2024
Opioid use, postoperative complications, and implant survival after unicompartmental versus total knee replacement: a population-based network studyEdward Burn, James Weaver, Daniel Morales, et al.
Histochemistry and Cell Biology|May 18, 2021
C(3)1-TAg in C57BL/6 J background as a model to study mammary tumor developmentIsadora F G Sena, Beatriz G S Rocha, Caroline C Picoli, et al.
Medrxiv : the Preprint Server for Health Sciences|April 1, 2021
Alpha-1 blockers and susceptibility to COVID-19 in benign prostate hyperplasia patients : an international cohort studyAkihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Drug Safety|June 2, 2022
Phenotype Algorithms for the Identification and Characterization of Vaccine-Induced Thrombotic Thrombocytopenia in Real World Data: A Multinational Network Cohort StudyAzza Shoaibi, Gowtham A Rao, Erica A Voss, et al.
Frontiers in Pharmacology|October 3, 2022
International cohort study indicates no association between alpha-1 blockers and susceptibility to COVID-19 in benign prostatic hyperplasia patientsAkihiko Nishimura, Junqing Xie, Kristin Kostka, et al.
Seminars in Arthritis and Rheumatism|June 21, 2022
Development and external validation of prediction models for adverse health outcomes in rheumatoid arthritis: A multinational real-world cohort analysisCynthia Yang, Ross D Williams, Joel N Swerdel, et al.
NPJ Precision Oncology|November 28, 2018
Superhydrophobic lab-on-chip measures secretome protonation state and provides a personalized risk assessment of sporadic tumourN Malara, F Gentile, N Coppedè, et al.
Pageof 9